Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
47T9JGCJtAxMxcSP